I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Jiang, Yingzhi
121
results:
Search for persons
X
Format
Online (121)
Mediatypes
Articles (Online) (72)
Bookchapter (Online) (6)
OpenAccess-fulltext (43)
Sorted by: Relevance
Sorted by: Year
?
1
Ningetinib plus gefitinib in EGFR-mutant non-small-cell lun..:
Zhao, Shen
;
Ma, Yuxiang
;
Liu, Lianke
...
Lung Cancer. 188 (2024) - p. 107468 , 2024
Link:
https://doi.org/10.1016/..
?
2
Preclinical characterization and phase I clinical trial of ..:
Ma, Yu-Xiang
;
Liu, Fu-Rong
;
Zhang, Yang
...
Frontiers in Immunology. 13 (2022) - p. , 2022
Link:
https://doi.org/10.3389/..
?
3
Larotinib in patients with advanced and previously treated ..:
Liu, Rongrui
;
Liu, Lianke
;
Zhao, Chuanhua
...
BMC Gastroenterology. 21 (2021) 1 - p. , 2021
Link:
https://doi.org/10.1186/..
?
4
Bioconversion of bamboo shoot shells through the cultivatio..:
Li, Haibin
;
He, Zhixiao
;
Jiang, Yingzhi
...
Ecotoxicology. 30 (2020) 7 - p. 1476-1486 , 2020
Link:
https://doi.org/10.1007/..
?
5
Lentivirus-mediated silencing of I2PP2A through RNA interfe..:
Yang, Xifei
;
Jiang, Yingzhi
;
Li, Jie
...
Toxicology Letters. 209 (2012) 3 - p. 232-238 , 2012
Link:
https://doi.org/10.1016/..
?
6
DNA loaded carrier preferential extravasation from tumor bl..:
Jiang, Ge
;
Jiang, Yingzhi
;
Shen, Yuanyuan
...
International Journal of Pharmaceutics. 369 (2009) 1-2 - p. 155-161 , 2009
Link:
https://doi.org/10.1016/..
?
7
Identification of antigenic proteins associated with trichl..:
Liu, Jianjun
;
Xing, Xiumei
;
Huang, Haiyan
...
Toxicology and Applied Pharmacology. 240 (2009) 3 - p. 393-400 , 2009
Link:
https://doi.org/10.1016/..
?
8
Preclinical characterization and phase I clinical trial of ..:
Ma, Yu-Xiang
;
Liu, Fu-Rong
;
Zhang, Yang
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632963/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
9
Larotinib in patients with advanced and previously treated ..:
Liu, Rongrui
;
Liu, Lianke
;
Zhao, Chuanhua
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540164/. , 2021
Link:
http://www.ncbi.nlm.nih...
?
10
Larotinib in patients with advanced and previously treated ..:
Rongrui Liu
;
Lianke Liu
;
Chuanhua Zhao
...
https://doi.org/10.1186/s12876-021-01982-4. , 2021
Link:
https://doi.org/10.1186/..
?
11
Additional file 3 of Larotinib in patients with advanced an..:
Rongrui Liu (11599333)
;
Lianke Liu (565583)
;
Chuanhua Zhao (11599336)
...
https://figshare.com/articles/journal_contribution/Additional_file_3_of_Larotinib_in_patients_with_advanced_and_previously_treated_esophageal_squamous_cell_carcinoma_with_epidermal_growth_factor_receptor_overexpression_or_amplification_an_open-label_multicenter_phase_1b_study/16863697. , 2021
Link:
https://doi.org/10.6084/..
?
12
Additional file 8 of Larotinib in patients with advanced an..:
Rongrui Liu (11599333)
;
Lianke Liu (565583)
;
Chuanhua Zhao (11599336)
...
https://figshare.com/articles/journal_contribution/Additional_file_8_of_Larotinib_in_patients_with_advanced_and_previously_treated_esophageal_squamous_cell_carcinoma_with_epidermal_growth_factor_receptor_overexpression_or_amplification_an_open-label_multicenter_phase_1b_study/16863712. , 2021
Link:
https://doi.org/10.6084/..
?
13
Additional file 1 of Larotinib in patients with advanced an..:
Rongrui Liu (11599333)
;
Lianke Liu (565583)
;
Chuanhua Zhao (11599336)
...
https://figshare.com/articles/journal_contribution/Additional_file_1_of_Larotinib_in_patients_with_advanced_and_previously_treated_esophageal_squamous_cell_carcinoma_with_epidermal_growth_factor_receptor_overexpression_or_amplification_an_open-label_multicenter_phase_1b_study/16863691. , 2021
Link:
https://doi.org/10.6084/..
?
14
Additional file 6 of Larotinib in patients with advanced an..:
Rongrui Liu (11599333)
;
Lianke Liu (565583)
;
Chuanhua Zhao (11599336)
...
https://figshare.com/articles/journal_contribution/Additional_file_6_of_Larotinib_in_patients_with_advanced_and_previously_treated_esophageal_squamous_cell_carcinoma_with_epidermal_growth_factor_receptor_overexpression_or_amplification_an_open-label_multicenter_phase_1b_study/16863706. , 2021
Link:
https://doi.org/10.6084/..
?
15
Additional file 5 of Larotinib in patients with advanced an..:
Rongrui Liu (11599333)
;
Lianke Liu (565583)
;
Chuanhua Zhao (11599336)
...
https://figshare.com/articles/journal_contribution/Additional_file_5_of_Larotinib_in_patients_with_advanced_and_previously_treated_esophageal_squamous_cell_carcinoma_with_epidermal_growth_factor_receptor_overexpression_or_amplification_an_open-label_multicenter_phase_1b_study/16863703. , 2021
Link:
https://doi.org/10.6084/..
1-15
